Skip to main content

D. E. Shaw & Co., Inc.

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in ZNTL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,472,788
+$1,231,278 QoQ
Shares Held
1,484,098
-10.6% QoQ
Ownership
2.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZNTL Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. ZNTL ranks #101 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ZNTL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,472,788 1,484,098
2025-12-31 $2,241,510 1,660,378
2025-09-30 $2,127,292 1,408,803
2025-06-30 $1,389,243 1,197,624
2025-03-31 $1,777,264 1,117,777
2024-12-31 $3,755,560 1,239,459
2024-09-30 $4,153,163 1,128,577
2024-06-30 $982,994 240,341
2024-03-31 $225,226 14,291
2023-09-30 $751,026 37,439
2022-09-30 $630,565 29,112
2022-06-30 $1,538,334 54,745
2022-03-31 $967,048 20,959
2021-12-31 $1,520,813 18,092
2021-09-30 $3,627,748 54,438
2021-06-30 $3,003,352 56,454
2021-03-31 $961,999 22,171
2020-12-31 $2,352,206 45,287
2020-09-30 $261,291 7,993
2020-06-30 $1,197,378 24,935